BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33596996)

  • 1. DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer.
    Goldmann T; Schmitt B; Müller J; Kröger M; Scheufele S; Marwitz S; Nitschkowski D; Schneider MA; Meister M; Muley T; Thomas M; Kugler C; Rabe KF; Siebert R; Reck M; Ammerpohl O
    Clin Epigenetics; 2021 Feb; 13(1):38. PubMed ID: 33596996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoscopic Brushing from Central Lung Cancer-Next Generation Sequencing Results are Reliable.
    Hagmeyer L; Fassunke J; Engels M; Treml M; Herkenrath S; Matthes S; Büttner R; Randerath W
    Lung; 2019 Jun; 197(3):333-337. PubMed ID: 30824994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide gene-age interaction analysis reveals reversed effects of
    Chen C; Wei Y; Wei L; Chen J; Chen X; Dong X; He J; Lin L; Zhu Y; Huang H; You D; Lai L; Shen S; Duan W; Su L; Shafer A; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Zhang R; Chen F; Christiani DC
    Aging (Albany NY); 2020 Jun; 12(11):10642-10662. PubMed ID: 32511103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility and accuracy of molecular testing in specimens obtained with small biopsy forceps: comparison with the results of surgical specimens.
    Oki M; Yatabe Y; Saka H; Kitagawa C; Kogure Y; Ichihara S; Moritani S
    Respiration; 2015; 89(3):235-42. PubMed ID: 25676841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of the bronchoscopic DNA content analysis of non-small-cell lung carcinoma.
    Haneda H; Miyamoto H; Isobe H; Abe S; Akita H; Ishikuro A; Kawakami Y; Okayasu K; Endo T; Inoue K
    J Surg Oncol; 1992 Mar; 49(3):182-8. PubMed ID: 1312655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of screening sensitive methylation sites using whole-genome sequencing in early diagnosis of non-small cell lung cancer.
    Zhang Y; Lu N; Pu S; Mu K
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):218-226. PubMed ID: 35818250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
    Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation markers for diagnosis and prognosis of common cancers.
    Hao X; Luo H; Krawczyk M; Wei W; Wang W; Wang J; Flagg K; Hou J; Zhang H; Yi S; Jafari M; Lin D; Chung C; Caughey BA; Li G; Dhar D; Shi W; Zheng L; Hou R; Zhu J; Zhao L; Fu X; Zhang E; Zhang C; Zhu JK; Karin M; Xu RH; Zhang K
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7414-7419. PubMed ID: 28652331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viability of lymph node samples obtained by echobronchoscopy in the study of epigenetic alterations in patients with lung cancer.
    Leiro-Fernández V; De Chiara L; Botana-Rial M; González-Piñeiro A; Tardio-Baiges A; Núñez-Delgado M; Valverde Pérez D; Fernández-Villar A
    Arch Bronconeumol; 2014 Jun; 50(6):213-20. PubMed ID: 24388707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.
    van den Berg RM; Snijders PJ; Grünberg K; Kooi C; Spreeuwenberg MD; Meijer CJ; Postmus PE; Smit EF; Steenbergen RD
    Lung Cancer; 2011 Jun; 72(3):316-21. PubMed ID: 21067843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.
    Freeman JR; Chu S; Hsu T; Huang YT
    Oncotarget; 2016 Oct; 7(43):69579-69591. PubMed ID: 27602958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
    Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
    PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
    Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
    Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung adenocarcinomas diagnosed by open lung or thoracoscopic vs bronchoscopic biopsy.
    Nomori H; Horio H; Fuyuno G; Kobayashi R; Morinaga S; Suemasu K
    Chest; 1998 Jul; 114(1):40-4. PubMed ID: 9674445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.